254 related articles for article (PubMed ID: 19860220)
1. [Updated cervical cancer screening; human papilloma virus and Papanicolaou tests].
Sasagawa T
Rinsho Byori; 2009 Sep; 57(9):905-12. PubMed ID: 19860220
[TBL] [Abstract][Full Text] [Related]
2. [Cost effectiveness of human papilloma virus testing in cervical cancer screening: a literature review].
Mejía A; Salas W
Biomedica; 2008 Mar; 28(1):160-72. PubMed ID: 18645671
[TBL] [Abstract][Full Text] [Related]
3. [Integrating HPV testing for primary screening?].
Riethmuller D; Ramanah R; Pretet JL; Mougin C
J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S139-51. PubMed ID: 18191912
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
[TBL] [Abstract][Full Text] [Related]
5. Updated approach to screening for cervical cancer in older women.
Celentano DD
Geriatrics; 1988 Apr; 43(4):37-8, 40-4, 48. PubMed ID: 2832258
[TBL] [Abstract][Full Text] [Related]
6. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
Ivanov S
Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer screening programs in low-income communities. Experiences from Ecuador. Low cost detection of HPV infection in a developing country.
Cecchini G; Paganini G; D'Amico M; Cannone M; Bertuletti C; Barberis MC
Pathologica; 2009 Apr; 101(2):76-9. PubMed ID: 19886552
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
[TBL] [Abstract][Full Text] [Related]
9. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
[TBL] [Abstract][Full Text] [Related]
10. High-risk HPV DNA detected in less than 2% of over 25,000 cytology negative imaged liquid-based Pap test samples from women 30 and older.
Bansal M; Austin RM; Zhao C
Gynecol Oncol; 2009 Nov; 115(2):257-61. PubMed ID: 19665217
[TBL] [Abstract][Full Text] [Related]
11. [Cervical cancer screening: current status and perspectives].
Petignat P; Bouchardy C; Sauthier P
Rev Med Suisse; 2006 May; 2(66):1308-9, 1311-2. PubMed ID: 16775991
[TBL] [Abstract][Full Text] [Related]
12. [The significance of the combined usage of cytology and the HPV test in cervical cancer screening].
Kina K; Ishi K; Hashizume A; Saeki H; Shiono S; Nagai F; Nojima M
Rinsho Byori; 2009 Sep; 57(9):913-7. PubMed ID: 19860221
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.
Howell LP; Gurusinghe S; Tabnak F; Sciortino S
Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426
[TBL] [Abstract][Full Text] [Related]
14. Effective cervical cytology screening programmes in middle-income countries: the Chilean experience.
Sepúlveda C; Prado R
Cancer Detect Prev; 2005; 29(5):405-11. PubMed ID: 16188399
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and cost-effectiveness of nationwide cervical cancer screening in Taiwan.
Koong SL; Yen AM; Chen TH
J Med Screen; 2006; 13 Suppl 1():S44-7. PubMed ID: 17227642
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer screening among elderly urban women in a primary care setting.
Wong QC; Collins R; Kalkstein K; Roth A; Gintautas J
Proc West Pharmacol Soc; 2005; 48():154-6. PubMed ID: 16416686
[TBL] [Abstract][Full Text] [Related]
18. Integrating human papillomavirus vaccination in cervical cancer control programmes.
Franco EL; Coutlée F; Ferenczy A
Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
[TBL] [Abstract][Full Text] [Related]
19. Decreasing cervical cancer mortality in Mexico: effect of Papanicolaou coverage, birthrate, and the importance of diagnostic validity of cytology.
Lazcano-Ponce E; Palacio-Mejia LS; Allen-Leigh B; Yunes-Diaz E; Alonso P; Schiavon R; Hernandez-Avila M
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2808-17. PubMed ID: 18843027
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of cervical cancer screening over cervical cancer mortality among Japanese women.
Aklimunnessa K; Mori M; Khan MM; Sakauchi F; Kubo T; Fujino Y; Suzuki S; Tokudome S; Tamakoshi A; ; Motohashi Y; Tsuji I; Nakamura Y; Iso H; Mikami H; Inaba Y; Hoshiyama Y; Suzuki H; Shimizu H; Toyoshima H; Wakai K; Ito Y; Hashimoto S; Kikuchi S; Koizumi A; Kawamura T; Watanabe Y; Miki T; Date C; Sakata K; Nose T; Hayakawa N; Yoshimura T; Shibata A; Okamoto N; Shino H; Ohno Y; Kitagawa T; Kuroki T; Tajima K
Jpn J Clin Oncol; 2006 Aug; 36(8):511-8. PubMed ID: 16844732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
